SYNTHESIS OF L-2-OXOTHIAZOLIDINE-4-CARBOXYLIC ACID

被引：0

作者：

BOETTCHER, B ^{[1
]}

MEISTER, A ^{[1
]}

机构：

[1] CORNELL UNIV,MED CTR,COLL MED,DEPT BIOCHEM,NEW YORK,NY 10021

来源：

METHODS IN ENZYMOLOGY | 1985年 / 113卷

关键词：

D O I：

暂无

中图分类号：

Q5 [生物化学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

收藏

页码：458 / 460

页数：3

相关论文

共 50 条

[21] Pyroglutamyl aminopeptidase I, as a drug metabolizing enzyme, recognizes xenobiotic substrates containing L-2-oxothiazolidine-4-carboxylic acid [J].

Abe, K ;

Saito, F ;

Yamada, M ;

Tokui, T .

BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2004, 27 (01) :113-116

[22] L-2-oxothiazolidine-4-carboxylic acid: a novel antioxidant agent that protects cadmium-induced thromboembolic events in mice [J].

Fahim, Mohamed ;

Nemmar, Abderrahim ;

Shafiullah, Mohamed ;

Javed, Mohamed ;

Hasan, Mohamed .

FASEB JOURNAL, 2014, 28 (01)

[23] L-2-Oxothiazolidine-4-Carboxylic Acid Mitigates the Thromboembolic Effects and Systemic Toxicityinduced by Sub-acute Exposure to Cadmiumin Mice [J].

Fahim, Mohamed ;

Nemmar, Abderrahim ;

Singh, Sarabjit ;

Shafiullah, Mohamed ;

Yasin, Javed ;

Hasan, Mohamed .

FASEB JOURNAL, 2015, 29

[24] A phase I/II evaluation of oral L-2-oxothiazolidine-4-carboxylic acid in asymptomatic patients infected with human immunodeficiency virus [J].

Barditch-Crovo, P ;

Noe, D ;

Skowron, G ;

Lederman, M ;

Kalayjian, RC ;

Borum, P ;

Buier, R ;

Rowe, WB ;

Goldberg, D ;

Lietman, P .

JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 38 (04) :357-363

[25] DETERMINATION OF L-2-OXOTHIAZOLIDINE-4-CARBOXYLIC ACID (PROCYSTEINE(R)) IN HUMAN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].

WEBB, LE ;

GECHMAN, M ;

STORY, K .

JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1994, 654 (02) :257-262

[26] Antidiabetic effect of a prodrug of cysteine, L-2-oxothiazolidine-4-carboxylic acid, through CD38 dimerization and internalization [J].

Han, MK ;

Kim, SJ ;

Park, YR ;

Shin, YM ;

Park, HJ ;

Park, KJ ;

Park, KH ;

Kim, HK ;

Jang, SI ;

An, NH ;

Kim, UH .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (07) :5315-5321

[27] L-2-oxothiazolidine-4-carboxylic acid inhibits human immunodeficiency virus type 1 replication in mononuclear phagocytes and lymphocytes [J].

Ho, WZ ;

Starr, SE ;

Sison, A ;

Douglas, SD .

CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1997, 4 (03) :352-357

[28] A PHASE I/II TRIAL OF INTRAVENOUS L-2-OXOTHIAZOLIDINE-4-CARBOXYLIC ACID (PROCYSTEINE) IN ASYMPTOMATIC HIV-INFECTED SUBJECTS [J].

KALAYJIAN, RC ;

SKOWRON, G ;

EMGUSHOV, RT ;

CHANCE, M ;

SPELL, SA ;

BORUM, PR ;

WEBB, LS ;

MAYER, KH ;

JACKSON, JB ;

YENLIEBERMAN, B ;

STORY, KO ;

ROWE, WB ;

THOMPSON, K ;

GOLDBERG, D ;

TRIMBO, S ;

LEDERMAN, MM .

JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1994, 7 (04) :369-374

[29] Production of IL-8 by pancreatic acinar cells is inhibited by vitamin E, dexamethasone, and L-2-oxothiazolidine-4-carboxylic acid [J].

Blanchard, JA ;

Talwalker, R ;

Gates, LK .

GASTROENTEROLOGY, 1996, 110 (04) :A378-A378

[30] PULMONARY EXPOSURE TO DIESEL PARTICLES PROMOTES CEREBRAL MICROVESSEL THROMBOSIS: PROTECTIVE EFFECT OF A CYSTEINE PRODRUG L-2-OXOTHIAZOLIDINE-4-CARBOXYLIC ACID [J].

Nemmar, A. ;

Al-Salam, S. ;

Dhanasekaran, S. ;

Ali, B. H. .

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 105 :127-127

← 1 2 3 4 5 →